Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Auditor change
Credit agrmnt [a]
Acq. announced
Syneos Health, Inc. (SYNH) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Syneos Health Appoints Colin Shannon as Chief Executive Officer"
09/28/2023 8-K Quarterly results
08/03/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
05/10/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Agreement and Plan of Merger, by and among Star Parent, Inc., Star Merger Sub, Inc. and Syneos Health, Inc. (filed herewith)"
05/10/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Syneos Health Reports First Quarter 2023 Results"
05/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion"
05/02/2023 8-K Quarterly results
03/30/2023 8-K Quarterly results
01/09/2023 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Separation Agreement and General Release of Claims between Jason Meggs and Syneos Health, Inc.",
"Consulting Agreement between Jason Meggs and Syneos Health, Inc.",
"Syneos Health Announces Chief Financial Officer Transition"
12/23/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Fourth Amended and Restated Bylaws of Syneos Health, Inc",
"Fourth Amended and Restated Bylaws of Syneos Health, Inc., marked to show amendments"
11/07/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amended & Restated Credit Agreement, among Syneos Health, Inc., Syneos Health US, Inc., the lenders party thereto, JPMorgan Chase Bank N.A. (“JPMorgan”), as Administrative Agent and Collateral Agent, and each of the other parties thereto"
11/03/2022 8-K Quarterly results
10/14/2022 8-K Resignation/termination of a director
09/12/2022 8-K Investor presentation
Docs: "Presentation"
08/01/2022 8-K Quarterly results
Docs: "Syneos Health Reports Second Quarter 2022 Results • Revenue for the second quarter of $1,360.7 million increased 6.1% on a reported basis and 8.3% on a constant currency basis year-over-year. • Clinical Solutions net new business awards and book-to-bill ratios: o Including reimbursable out-of-pocket expenses, $947.4 million for the second quarter, a year-over-year decline of 34.2% and a book-to-bill ratio of 0.92x, and $3,901.5 million for the trailing twelve months, a year-over-year decline of 21.7% and a book-to-bill ratio of 0.94x. o Excluding reimbursable out-of-pocket expenses, $758.5 million for the second quarter, a year-over-year decline of 15.1% and a book-to-bill ratio of 1.06x, and $3,608.6 million for the trailing twelve months, year-over-year growth of 10.5% and ..."
06/01/2022 8-K Quarterly results
04/29/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement between the Company and Michelle Keefe",
"Letter Agreement between the Company and Michael Brooks",
"Agreement between Syneos Health UK Limited and Alistair Macdonald",
"Consulting Agreement between the Company and Alistair Macdonald"
04/28/2022 8-K Quarterly results
Docs: "Syneos Health Reports First Quarter 2022 Results"
02/16/2022 8-K Quarterly results
Docs: "Syneos Health Reports Fourth Quarter and Full Year 2021 Results"
11/16/2021 8-K Resignation/termination of a director
11/15/2021 8-K Regulation FD Disclosure  Interactive Data
08/06/2021 8-K Quarterly results
07/01/2021 8-K Quarterly results
06/16/2021 8-K Quarterly results
06/04/2021 8-K Quarterly results
05/14/2021 8-K Quarterly results
05/05/2021 8-K Quarterly results
04/28/2021 8-K Quarterly results
Docs: "Syneos Health Reports First Quarter 2021 Results"
03/03/2021 8-K Quarterly results
02/17/2021 8-K Quarterly results
01/21/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Form of Global Performance Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan (U.S. Participants)",
"Form of Global Performance Restricted Stock Unit Award Agreement under Syneos Health, Inc. 2018 Equity Incentive Plan (Non-U.S. Participants)"
01/12/2021 8-K Investor presentation
Docs: "Presentation"
12/23/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/03/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement, by and among Syneos Health, Inc., the selling stockholders named therein and Goldman Sachs & Co. LLC and BofA Securities, Inc",
"Opinion of Latham & Watkins LLP"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy